STOCK TITAN

Amwell announces innovation leader as chief product and technology officer

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Amwell (NYSE: AMWL) has appointed Dan Zamansky as its new chief product and technology officer, effective March 03, 2025. Zamansky, an Amazon veteran with over a decade of experience, will lead the company's product and R&D organizations.

At Amazon, Zamansky founded and led AWS Health AI, the company's cloud initiative focused on democratizing AI technology access for healthcare customers. He also managed product and technology teams across AWS and Amazon Ads initiatives.

In his new role, Zamansky will focus on Amwell's technology-enabled care platform for payers and health systems, ensuring its evolution to meet increasing online care demands. He succeeds Vaughn Paunovich, who has served since 2022 and led the company through a re-platforming phase.

Amwell (NYSE: AMWL) ha nominato Dan Zamansky come nuovo direttore prodotto e tecnologia, con effetto dal 3 marzo 2025. Zamansky, un veterano di Amazon con oltre un decennio di esperienza, guiderà le organizzazioni prodotto e R&D dell'azienda.

Presso Amazon, Zamansky ha fondato e guidato AWS Health AI, l'iniziativa cloud dell'azienda focalizzata sulla democratizzazione dell'accesso alla tecnologia AI per i clienti del settore sanitario. Ha anche gestito team di prodotto e tecnologia all'interno delle iniziative AWS e Amazon Ads.

Nel suo nuovo ruolo, Zamansky si concentrerà sulla piattaforma di assistenza abilitata dalla tecnologia di Amwell per i pagatori e i sistemi sanitari, garantendo la sua evoluzione per soddisfare le crescenti richieste di assistenza online. Sostituisce Vaughn Paunovich, che ha ricoperto il ruolo dal 2022 e ha guidato l'azienda attraverso una fase di re-platforming.

Amwell (NYSE: AMWL) ha nombrado a Dan Zamansky como su nuevo director de producto y tecnología, con efecto a partir del 3 de marzo de 2025. Zamansky, un veterano de Amazon con más de una década de experiencia, liderará las organizaciones de producto e I+D de la empresa.

En Amazon, Zamansky fundó y dirigió AWS Health AI, la iniciativa en la nube de la empresa centrada en democratizar el acceso a la tecnología de IA para los clientes del sector salud. También gestionó equipos de producto y tecnología en las iniciativas de AWS y Amazon Ads.

En su nuevo papel, Zamansky se enfocará en la plataforma de atención habilitada por tecnología de Amwell para pagadores y sistemas de salud, asegurando su evolución para satisfacer la creciente demanda de atención en línea. Sucede a Vaughn Paunovich, quien ha estado en el cargo desde 2022 y ha guiado a la empresa a través de una fase de re-platforming.

Amwell (NYSE: AMWL)는 Dan Zamansky를 새로운 제품 및 기술 책임자로 임명했으며, 2025년 3월 3일부터 효력이 발생합니다. Zamansky는 10년 이상의 경험을 가진 아마존 베테랑으로, 회사의 제품 및 연구개발 조직을 이끌게 됩니다.

아마존에서 Zamansky는 AWS Health AI를 설립하고 이끌었으며, 이는 의료 고객을 위한 AI 기술 접근을 민주화하는 데 중점을 둔 회사의 클라우드 이니셔티브입니다. 그는 또한 AWS 및 아마존 광고 이니셔티브의 제품 및 기술 팀을 관리했습니다.

새로운 역할에서 Zamansky는 지불자 및 건강 시스템을 위한 Amwell의 기술 기반 치료 플랫폼에 집중하여 온라인 치료 수요 증가에 맞춰 발전할 수 있도록 보장할 것입니다. 그는 2022년부터 재임해온 Vaughn Paunovich의 뒤를 잇게 됩니다.

Amwell (NYSE: AMWL) a nommé Dan Zamansky comme nouveau directeur des produits et de la technologie, à compter du 3 mars 2025. Zamansky, un vétéran d'Amazon avec plus d'une décennie d'expérience, dirigera les organisations produit et R&D de l'entreprise.

Chez Amazon, Zamansky a fondé et dirigé AWS Health AI, l'initiative cloud de l'entreprise axée sur la démocratisation de l'accès à la technologie AI pour les clients du secteur de la santé. Il a également géré des équipes produit et technologie dans les initiatives AWS et Amazon Ads.

Dans son nouveau rôle, Zamansky se concentrera sur la plateforme de soins habilitée par la technologie d'Amwell pour les payeurs et les systèmes de santé, garantissant son évolution pour répondre à la demande croissante de soins en ligne. Il succède à Vaughn Paunovich, qui a occupé le poste depuis 2022 et a dirigé l'entreprise à travers une phase de re-platforming.

Amwell (NYSE: AMWL) hat Dan Zamansky zum neuen Chief Product and Technology Officer ernannt, der am 3. März 2025 in Kraft tritt. Zamansky, ein Amazon-Veteran mit über einem Jahrzehnt Erfahrung, wird die Produkt- und F&E-Organisationen des Unternehmens leiten.

Bei Amazon gründete und leitete Zamansky AWS Health AI, die Cloud-Initiative des Unternehmens, die sich darauf konzentriert, den Zugang zu KI-Technologie für Gesundheitskunden zu demokratisieren. Er leitete auch Produkt- und Technologie-Teams in den Initiativen von AWS und Amazon Ads.

In seiner neuen Rolle wird Zamansky sich auf die technologiegestützte Pflegeplattform von Amwell für Zahler und Gesundheitssysteme konzentrieren und sicherstellen, dass sie sich weiterentwickelt, um der wachsenden Nachfrage nach Online-Pflege gerecht zu werden. Er folgt auf Vaughn Paunovich, der seit 2022 im Amt ist und das Unternehmen durch eine Re-Plattformierungsphase geleitet hat.

Positive
  • Strategic hire of experienced tech executive from Amazon/AWS
  • Strengthening AI and healthcare technology capabilities
  • Focus on operational efficiency and profitable growth
Negative
  • Executive turnover with departure of previous technology officer

Amazon veteran Dan Zamansky joins company’s executive team

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company’s new chief product and technology officer, effective today.

Zamansky will lead the company's product and R&D organizations. He will focus on the comprehensive technology-enabled care platform Amwell offers payers and health systems to provide individuals with better access to more convenient, affordable and effective care. In addition, as more people seek care online and more clinical programs are available, Zamansky will ensure the Amwell platform continues to evolve and provide clients with an integrated future-ready solution.

Zamansky joins Amwell after more than a decade at Amazon, where he held leadership roles in product management, engineering and technology. Zamansky founded and led AWS Health AI, the company’s cloud initiative to democratize access to cutting-edge Artificial Intelligence technology to AWS healthcare and life sciences customers. He also oversaw product and technology teams across initiatives at AWS and Amazon Ads. Zamansky has extensive experience building and scaling platforms that support a variety of customer needs.

“Dan’s proven track record leading global and cross-functional teams responsible for platform services, AI and product management give him the right mix of experience to drive synergies and support Amwell’s path to profitable growth while powering the digital care aspirations of our clients,” said Ido Schoenberg, M.D., chairman and CEO of Amwell. “He has an appreciation for our core platform business and our culture of continuous improvement. Dan will be an excellent addition to our leadership team as we continue to sharpen our operational focus on key priorities, driving efficiencies, optimizing cash flow and delivering profitable growth while pursuing our mission to redefine healthcare delivery through technology-enabled solutions.”

Zamansky succeeds Vaughn Paunovich, who has been with Amwell since 2022. Schoenberg said, “I want to thank Vaughn for his many contributions. He guided Amwell through a time of re-platforming, resulting in a more efficient and effective R&D organization. His partnership, expertise and leadership have been invaluable to our team.”

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.


FAQ

Who is the new chief product and technology officer at Amwell (AMWL)?

Dan Zamansky, a former Amazon executive who led AWS Health AI, has been appointed as Amwell's new chief product and technology officer effective March 03, 2025.

What was Dan Zamansky's role at Amazon before joining Amwell (AMWL)?

Zamansky founded and led AWS Health AI and managed product and technology teams across AWS and Amazon Ads initiatives during his decade-long tenure at Amazon.

What will be Zamansky's main responsibilities at Amwell (AMWL)?

He will lead Amwell's product and R&D organizations, focusing on developing the company's technology-enabled care platform for payers and health systems.

Who did Dan Zamansky replace as Amwell's (AMWL) chief product and technology officer?

Zamansky succeeds Vaughn Paunovich, who served since 2022 and led Amwell through a re-platforming phase.

American Well Corp

NYSE:AMWL

AMWL Rankings

AMWL Latest News

AMWL Stock Data

156.26M
12.54M
6.23%
49.25%
2.32%
Health Information Services
Services-business Services, Nec
Link
United States
Boston